Published by mark itwired
Posted on September 10, 2021
10 min readLast updated: January 21, 2026
Global single-photon emission computed tomography market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by the rise in prevalence of chronic disorders, growing disease awareness levels among the population, and development of cost-effective and advanced treatment options. According to the newly published report by Future Market Insights titled “Single-Photon Emission Computed Tomography Market: Global Industry Analysis and Opportunity Assessment” revenue from the global single-photon emission computed tomography market is expected to increase at a CAGR of 6.9% during the forecast period 2017–2027.
This market is fragmented with very few major players operating globally. Companies in the global market are focussing on driving growth in mature markets so as to maximise growth prospects. This exclusive report on the global single-photon emission computed tomography market indicates that North America represents the most lucrative market for single-photon emission computed tomography, followed by Western Europe and APEJ.
Regulatory impositions by various regulatory authorities in different countries as well as the rules and regulations laid down by the U.S. Food and Drug Administration and European Commission could affect the global single-photon emission computed tomography market. Also, currency fluctuations and changing taxation policies are likely to have a significant impact on the revenue growth of the global single-photon emission computed tomography market over the forecast period.
Get Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5826
On the basis of end user, the global market for single-photon emission computed tomography is segmented into hospitals, diagnostic imaging centres and ambulatory surgical centres. Although hospitals dominated the global SPECT market in 2016 with a valuation of US$ 898.7 Mn, diagnostic imaging centres are expected to witness significant growth during the forecast period 2017 – 2027, primarily due to the adoption of single-photon emission computed tomography devices in diagnostic imaging centres.
By product type the market is segmented into single imaging gamma cameras and SPECT/CT. The single imaging gamma cameras segment dominated the global SPECT market in 2016 and is projected to continue to do so throughout the forecast period. However, SPECT/CT is the fastest growing segment in the global market, expanding at a CAGR of 9.3% during the forecast period.
By application the global market for single-photon emission computed tomography is segmented into cardiology, oncology, neurology, and others. Neurology is the fastest growing segment by application type, expanding at a CAGR of 7.9% followed by oncology and cardiology.
The North America single-photon emission computed tomography market accounted for the largest revenue share in 2016. Asia Pacific excluding Japan is expected to experience the highest growth rate of 8.9% between 2017 and 2027, primarily due to rising incidences of chronic disorders and a rapid growth in the ageing population.
GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD., PNPMed, NuCare Inc. are some of the key market players profiled in this report.
Speak To Analyst For Queries about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-5826
A gist of the report, highlighting the key takeaways
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
A definition of single-photon emission computed tomography and related market taxonomy
2.1. Market Taxonomy
2.2. Market Definition
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Regional Pricing Analysis by Product Type
Market forecast and analysis in the U.S. and Canada
4.1. Introduction
4.2. Key Regulations
4.3. Regional Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Historical Market Size (US$ Mn) By Country, 2012-2016
4.4.1. U.S.
4.4.2. Canada
4.5. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.5.1. U.S.
4.5.2. Canada
4.6. Historical Market Size (US$ Mn) and Volume (Units) By Product Type, 2012-2016
4.6.1. Single Imaging Gamma Cameras
4.6.2. SPECT/CT
4.7. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2017-2027
4.7.1. Single Imaging Gamma Cameras
4.7.2. SPECT/CT
4.8. Historical Market Size (US$ Mn) By Application Type, 2012-2016
4.8.1. Cardiology
4.8.2. Oncology
4.8.3. Neurology
4.8.4. Others
4.9. Market Size (US$ Mn) Forecast By Application Type, 2017-2027
4.9.1. Cardiology
4.9.2. Oncology
4.9.3. Neurology
4.9.4. Others
4.10. Historical Market Size (US$ Mn) By End User, 2012-2016
4.10.1. Hospitals
4.10.2. Diagnostic Imaging Centers
4.10.3. Ambulatory Surgical Centers
4.11. Market Size (US$ Mn) Forecast By End User, 2017-2027
4.11.1. Hospitals
4.11.2. Diagnostic Imaging Centers
4.11.3. Ambulatory Surgical Centers
4.12. Drivers and Restraints: Impact Analysis
4.13. Market Attractiveness Analysis
4.13.1. By Country
4.13.2. By Product Type
4.13.3. By Application Type
4.13.4. By End User
4.14. Key Representative Market Participants
4.15. Key Participants Market Presence (Intensity Map)
Market forecast and analysis in Germany, France, Italy, Spain, U.K. and rest of Western Europe
5.1. Introduction
5.2. Key Regulations
5.3. Regional Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
The post Single-Photon Emission Computed Tomography Market Detail Research on Stakeholders, Business Prospects, Regional Analysis 2027 first appeared on Market Research Blog.
Global single-photon emission computed tomography market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by the rise in prevalence of chronic disorders, growing disease awareness levels among the population, and development of cost-effective and advanced treatment options. According to the newly published report by Future Market Insights titled “Single-Photon Emission Computed Tomography Market: Global Industry Analysis and Opportunity Assessment” revenue from the global single-photon emission computed tomography market is expected to increase at a CAGR of 6.9% during the forecast period 2017–2027.
This market is fragmented with very few major players operating globally. Companies in the global market are focussing on driving growth in mature markets so as to maximise growth prospects. This exclusive report on the global single-photon emission computed tomography market indicates that North America represents the most lucrative market for single-photon emission computed tomography, followed by Western Europe and APEJ.
Regulatory impositions by various regulatory authorities in different countries as well as the rules and regulations laid down by the U.S. Food and Drug Administration and European Commission could affect the global single-photon emission computed tomography market. Also, currency fluctuations and changing taxation policies are likely to have a significant impact on the revenue growth of the global single-photon emission computed tomography market over the forecast period.
Get Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5826
On the basis of end user, the global market for single-photon emission computed tomography is segmented into hospitals, diagnostic imaging centres and ambulatory surgical centres. Although hospitals dominated the global SPECT market in 2016 with a valuation of US$ 898.7 Mn, diagnostic imaging centres are expected to witness significant growth during the forecast period 2017 – 2027, primarily due to the adoption of single-photon emission computed tomography devices in diagnostic imaging centres.
By product type the market is segmented into single imaging gamma cameras and SPECT/CT. The single imaging gamma cameras segment dominated the global SPECT market in 2016 and is projected to continue to do so throughout the forecast period. However, SPECT/CT is the fastest growing segment in the global market, expanding at a CAGR of 9.3% during the forecast period.
By application the global market for single-photon emission computed tomography is segmented into cardiology, oncology, neurology, and others. Neurology is the fastest growing segment by application type, expanding at a CAGR of 7.9% followed by oncology and cardiology.
The North America single-photon emission computed tomography market accounted for the largest revenue share in 2016. Asia Pacific excluding Japan is expected to experience the highest growth rate of 8.9% between 2017 and 2027, primarily due to rising incidences of chronic disorders and a rapid growth in the ageing population.
GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD., PNPMed, NuCare Inc. are some of the key market players profiled in this report.
Speak To Analyst For Queries about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-5826
A gist of the report, highlighting the key takeaways
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
A definition of single-photon emission computed tomography and related market taxonomy
2.1. Market Taxonomy
2.2. Market Definition
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Regional Pricing Analysis by Product Type
Market forecast and analysis in the U.S. and Canada
4.1. Introduction
4.2. Key Regulations
4.3. Regional Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Historical Market Size (US$ Mn) By Country, 2012-2016
4.4.1. U.S.
4.4.2. Canada
4.5. Market Size (US$ Mn) Forecast By Country, 2017-2027
4.5.1. U.S.
4.5.2. Canada
4.6. Historical Market Size (US$ Mn) and Volume (Units) By Product Type, 2012-2016
4.6.1. Single Imaging Gamma Cameras
4.6.2. SPECT/CT
4.7. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2017-2027
4.7.1. Single Imaging Gamma Cameras
4.7.2. SPECT/CT
4.8. Historical Market Size (US$ Mn) By Application Type, 2012-2016
4.8.1. Cardiology
4.8.2. Oncology
4.8.3. Neurology
4.8.4. Others
4.9. Market Size (US$ Mn) Forecast By Application Type, 2017-2027
4.9.1. Cardiology
4.9.2. Oncology
4.9.3. Neurology
4.9.4. Others
4.10. Historical Market Size (US$ Mn) By End User, 2012-2016
4.10.1. Hospitals
4.10.2. Diagnostic Imaging Centers
4.10.3. Ambulatory Surgical Centers
4.11. Market Size (US$ Mn) Forecast By End User, 2017-2027
4.11.1. Hospitals
4.11.2. Diagnostic Imaging Centers
4.11.3. Ambulatory Surgical Centers
4.12. Drivers and Restraints: Impact Analysis
4.13. Market Attractiveness Analysis
4.13.1. By Country
4.13.2. By Product Type
4.13.3. By Application Type
4.13.4. By End User
4.14. Key Representative Market Participants
4.15. Key Participants Market Presence (Intensity Map)
Market forecast and analysis in Germany, France, Italy, Spain, U.K. and rest of Western Europe
5.1. Introduction
5.2. Key Regulations
5.3. Regional Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
The post Single-Photon Emission Computed Tomography Market Detail Research on Stakeholders, Business Prospects, Regional Analysis 2027 first appeared on Market Research Blog.
Explore more articles in the Research Reports category
